Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Canada / NCT06638060
Recruiting Observational

Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Older Adults Department PHC

NCT06638060 · tracked via the Priya Life Science Canada tracker
Sponsor
Medtronic - MITG
Phase
Observational
Started
2025-03-13
Last updated
2026-10-15

Condition(s) studied

Aging

Study summary

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Inpatients on the Acute care of the Elderly ward. Exclusion Criteria: * Lack of capacity to consent to the study including moderate-severe dementia or delirium * Unable to use (or does not have a caregiver who can help put on) study monitoring device at home * Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone * Patient with known allergic reactions to any part material of the device * People under 40kg

Primary outcome measure(s)

  • Collect patient and clinicians' feedback about the CCPC Platform — From enrollment to the end of follow up at 10 days
    This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
  • Collect patient and clinicians' feedback about the CCPC Platform — From enrollment to the end of follow up at 10 days
    This will be completed via an assessment of the Usability Questionnaire.
  • Collect patient and clinicians' feedback about the CCPC Platform — From enrollment to the end of follow up at 10 days
    This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.
  • Confirm the technical goals of the CCPC platform are met. — From enrollment to the end of follow up at 10 days
    This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).
  • Confirm the technical goals of the CCPC platform are met. — From enrollment to the end of follow up at 10 days
    This will be completed via an assessment of the data flow: does the correct patient data reach the clinicians at the right time?
  • Confirm the technical goals of the CCPC platform are met. — From enrollment to the end of follow up at 10 days
    This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, labs and other collected data.

Trial sites (1)

FacilityCityRegionStatus
St. Paul'sHospital Vancouver British Columbia Recruiting

More Medtronic - MITG trials in Canada

Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Bleeding Recruiting
Continuous Connected Patient Care (CCPC), a Pilot Testing a Novel Device for Continuous Vitals Monitoring - Department of Anesthesia at PHC Active, not recruiting

Other trials for the same condition

Sleep Apnea and Cognition in Older Adults Recruiting
Personalized Exercises Program Prescription to Prevent Functional Decline Throughout Older Adults Hospitalization Recruiting
D3-Creatine and Skeletal Muscle in Older Adults Recruiting
Evaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program Enrolling by invitation
Threonine Requirement in Adults >60 Years of Age Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06638060 on ClinicalTrials.gov ↗ ← All trials in Canada